Psoriatic Arthritis Trial, Recruiting NCT05291819 Sponsor: Diakonhjemmet Hospital Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Psoriatic Arthritis Trial, Recruiting

NCT05291819
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years of age
  • You have been diagnosed with Psoriatic Arthritis (PsA) by a doctor
  • Your doctor has recommended you start a specific type of medication called a DMARD, and if your main symptoms are in your spine or tendons/ligament attachment points, you have already tried at least 2 anti-inflammatory painkillers (such as ibuprofen or naproxen) for a total of at least 4 weeks
  • You meet a specific set of recognised medical criteria used to confirm a diagnosis of Psoriatic Arthritis (called the CASPAR criteria) (confirm with trial site)

Who may not be able to join:

  • Your joint inflammation (arthritis) was confirmed more than 1 year before joining the trial
  • You have previously taken DMARD medications for your Psoriatic Arthritis
  • You have used steroid tablets or injections taken throughout the body (systemic steroids) in the last 3 months
  • You have had a steroid injection directly into a joint or affected area in the last 4 weeks
  • You have serious other health conditions, such as certain cancers, severe diabetes, serious or frequent infections, uncontrolled high blood pressure, severe heart disease, severe breathing problems, or severe liver scarring (cirrhosis)
  • You have signs of active or latent (hidden/inactive) tuberculosis (TB), unless you have already completed an adequate course of treatment for latent TB
  • You have any other medical condition that your doctor or local guidelines say would make it impossible to follow the treatment plan (confirm with trial site)
  • Your kidney function is significantly reduced, based on blood test results showing levels outside specified limits (confirm with trial site for exact values)
  • Your liver function is significantly reduced, or you have active or recent hepatitis (liver inflammation), based on blood test results
  • You have significantly low levels of red blood cells, white blood cells, or platelets in your blood
  • You are pregnant, breastfeeding, or planning to become pregnant during the study, or you are not using adequate contraception
  • You have a condition or implant that means you cannot safely have an MRI scan
  • You have a serious psychiatric or mental health condition, problems with alcohol or drug use, significant language barriers, or any other factor that would make it impossible to follow the study plan
  • You have been diagnosed with or are suspected to have a widespread pain condition such as fibromyalgia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Siri Lillegraven, MD, MPH, PhD, Diakonhjemmet

Phone: +4722451500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Diakonhjemmet Hospital
Registry
ClinicalTrials.gov
Start date
14 March 2022
Est. completion
31 December 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Sustained Remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov